Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01906840

Role of Turmeric on Oxidative Modulation in ESRD Patients

Evaluate the Effects of Turmeric on Oxidative Stress Markers in HD Patients

Sponsor: Shiraz University of Medical Sciences

Updated 5 times since 2017 Last updated: Jul 23, 2013 Started: Apr 30, 2011 Primary completion: Aug 31, 2012 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on End Stage Renal Failure, this trial is completed. The trial is conducted by Shiraz University of Medical Sciences and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shiraz University of Medical Sciences

Data source: Shiraz University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.